Price T Rowe Associates Inc Ideaya Biosciences, Inc. Transaction History

Price T Rowe Associates Inc

$836 Billion
Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,743,741 shares of IDYA stock, worth $112 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,743,741

Previous 4,052,500 7.62%

Holding current value

$112 Million

Previous $178 Million 26.08%

% of portfolio

0.02%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$34.37 - $43.46 $10.6 Million - $13.4 Million	-308,759 Reduced 7.62%	3,743,741 $131 Million
Q1 2024 May 15, 2024	BUY	$34.2 - $47.13 $16.6 Million - $22.9 Million	486,222 Added 13.63%	4,052,500 $178 Million
Q4 2023 Feb 14, 2024	BUY	$24.59 - $35.83 $13.2 Million - $19.2 Million	535,909 Added 17.68%	3,566,278 $127 Million
Q3 2023 Nov 14, 2023	BUY	$21.07 - $29.77 $11.1 Million - $15.7 Million	527,696 Added 21.09%	3,030,369 $81.8 Million
Q2 2023 Aug 14, 2023	BUY	$13.33 - $25.53 $13.8 Million - $26.5 Million	1,036,086 Added 70.65%	2,502,673 $58.8 Million
Q1 2023 May 15, 2023	SELL	$13.49 - $18.72 $2.66 Million - $3.69 Million	-196,941 Reduced 11.84%	1,466,587 $20.1 Million
Q4 2022 Feb 14, 2023	SELL	$14.47 - $18.17 $2.83 Million - $3.55 Million	-195,349 Reduced 10.51%	1,663,528 $30.2 Million
Q3 2022 Nov 14, 2022	SELL	$9.24 - $15.79 $252,945 - $432,251	-27,375 Reduced 1.45%	1,858,877 $27.7 Million
Q2 2022 Aug 15, 2022	SELL	$8.28 - $13.88 $1.89 Million - $3.17 Million	-228,741 Reduced 10.82%	1,886,252 $26 Million
Q1 2022 May 16, 2022	SELL	$11.18 - $24.02 $6.56 Million - $14.1 Million	-586,532 Reduced 21.71%	2,114,993 $23.7 Million
Q4 2021 Feb 14, 2022	BUY	$20.95 - $26.88 $7.66 Million - $9.83 Million	365,619 Added 15.65%	2,701,525 $63.9 Million
Q3 2021 Nov 15, 2021	BUY	$17.26 - $27.08 $17.7 Million - $27.8 Million	1,025,929 Added 78.32%	2,335,906 $59.5 Million
Q2 2021 Aug 16, 2021	BUY	$17.76 - $24.83 $7.28 Million - $10.2 Million	409,712 Added 45.51%	1,309,977 $27.5 Million
Q1 2021 May 17, 2021	BUY	$13.48 - $23.77 $5.79 Million - $10.2 Million	429,166 Added 91.1%	900,265 $21.2 Million
Q4 2020 Feb 16, 2021	BUY	$12.17 - $17.52 $5.73 Million - $8.25 Million	471,099 New	471,099 $6.6 Million

Others Institutions Holding IDYA

# of Institutions

213

Shares Held

73.8M

Call Options Held

21.5K

Put Options Held

20.3K

View Full List

About IDEAYA Biosciences, Inc.

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.44B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

More about IDYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Ideaya Biosciences, Inc. Transaction History